Description

D-Erythro-Hexonic Acid, 6-Amino-2,5-Anhydro-3,4,6-Trideoxy- is a specialized amino sugar derivative with significant potential in advanced organic synthesis. This compound is valued for its unique stereochemistry and functional groups, making it a versatile chiral building block and intermediate. It is primarily sought after by research institutions and pharmaceutical companies engaged in the development of novel therapeutics, complex carbohydrate chemistry, and the synthesis of nucleoside analogs. Its precise structure, identified by CAS 779358-51-9, enables the construction of molecules with specific biological activities.

Application

• Pharmaceutical Intermediate: Serves as a key chiral precursor in the synthesis of novel antiviral agents, antibiotics, and other bioactive molecules.
• Carbohydrate Chemistry Research: Used as a fundamental building block for constructing complex oligosaccharides, glycoconjugates, and glycomimetics.
• Nucleoside Analog Synthesis: A critical starting material for developing modified nucleosides with potential therapeutic applications.
• Biochemical Tool Development: Employed in the creation of enzyme inhibitors, receptor ligands, and probes for studying biological pathways.
• Fine Chemical Synthesis: Acts as a specialized intermediate for producing high-value, stereochemically defined compounds in custom synthesis projects.

Basic Information

Item	Details
Product Name	D-Erythro-Hexonic Acid, 6-Amino-2,5-Anhydro-3,4,6-Trideoxy-
CAS No.	779358-51-9
Molecular Formula	C6H11NO4
Molecular Weight	161.16 g/mol
Synonyms	6-Amino-2,5-anhydro-3,4,6-trideoxy-D-erythro-hexonic acid; 2,5-Anhydro-6-amino-3,4,6-trideoxy-D-erythro-hexonic acid; 6-Amino-2,5-anhydro-3,4,6-trideoxy-D-erythro-hexonolactone (cyclic form); D-erythro-6-Amino-2,5-anhydro-3,4,6-trideoxyhexonic acid; Amino-deoxyhexonic acid derivative; CAS 779358-51-9
EINECS	Contact for details

Quality Control

Our D-Erythro-Hexonic Acid, 6-Amino-2,5-Anhydro-3,4,6-Trideoxy- is produced under strict quality management protocols to ensure batch-to-batch consistency and high purity. Each lot undergoes comprehensive analytical testing, including HPLC for assay and purity, chiral analysis, and identification by spectroscopic methods. A Certificate of Analysis (COA) detailing all specifications is provided with every shipment. We support cGMP-compliant manufacturing for pharmaceutical applications and can tailor specifications to meet specific research or project requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive); therefore, the container must be kept tightly sealed in a dry environment to prevent absorption of moisture. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Purity (HPLC)	≥ 97.0%
Chiral Purity	≥ 99.0% ee
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.